EQT three-lens brief
Evidence-based stock research on EQT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 16.1pp over 30 days. · Debt-to-equity of 20.8 — balance-sheet-heavy.
- Underperforming SPY by 16.1pp over 30 days.
- P/E of 11.2 — trading at a value multiple.
- Analyst mean target $69.76 — 18% above current (25 analysts).
- Debt-to-equity of 20.8 — balance-sheet-heavy.
EQT closed at $58.91 (-0.03%) as of 2026-04-25. Market cap: $36.85B. P/E (trailing) 11.2. Positives: p/E of 11.2 — trading at a value multiple.; analyst mean target $69.76 — 18% above current (25 analysts).. Concerns: underperforming SPY by 16.1pp over 30 days.; debt-to-equity of 20.8 — balance-sheet-heavy.. Last quarter: Revenue $3.38B, net income $1.49B, free cash flow $2.50B.
Why three lenses on EQT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EQTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EQT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EQT brief"></iframe>